Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
Patni brings over 25 years of distinguished experience in the pharmaceutical industry
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
The use of procalcitonin testing for sepsis management is highest in the US
The company has been ranked 8th on the list this year for three key attributes: ‘innovative leader in the industry’, ‘is socially responsible’ and ‘has loyal employees’
Subscribe To Our Newsletter & Stay Updated
